129 related articles for article (PubMed ID: 25323616)
1. Management of young breast cancer patients with de novo genetic mutations.
Fisher CM; Klein CE; Kondapalli LA; Elias AD; Borges VF
Oncology (Williston Park); 2014 Oct; 28(10):895-6. PubMed ID: 25323616
[No Abstract] [Full Text] [Related]
2. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
[TBL] [Abstract][Full Text] [Related]
3. Significance of TP53 mutations determined by next-generation "deep" sequencing in prognosis of estrogen receptor-positive breast cancer.
Uji K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Cancer Lett; 2014 Jan; 342(1):19-26. PubMed ID: 23973262
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of apoptotic marker p53 as a prognostic factor in breast cancer.
Loskutova KS; Kirillina MP; Lushnikova EL; Nepomnyashchikh LM
Bull Exp Biol Med; 2014 Nov; 158(1):84-7. PubMed ID: 25403404
[TBL] [Abstract][Full Text] [Related]
5. A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.
Bowles DW; Rabinovitch R; Borges V; Urquhart A; Singh M; Finlayson C; Elias A
Oncology (Williston Park); 2007 Sep; 21(10):1212-7. PubMed ID: 17926799
[No Abstract] [Full Text] [Related]
6. Current issues in the management of breast cancer.
Hill AD; McDermott EW; O'Higgins NJ
Ir Med J; 1996; 89(2):46-8. PubMed ID: 8682624
[No Abstract] [Full Text] [Related]
7. Intramedullary spinal cord metastases in breast cancer are associated with improved longer-term systemic control.
Zebrowski A; Wilson L; Lim A; Stebbing J; Krell J
Future Oncol; 2010 Sep; 6(9):1517-9. PubMed ID: 20919834
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoma in situ. Prognostic factors].
Trojani M
Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
[No Abstract] [Full Text] [Related]
9. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of breast cancer: toward the individualization of therapy.
Chang JC; Hilsenbeck SG; Fuqua SA
Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
[No Abstract] [Full Text] [Related]
12. Palpable right breast mass in a pregnant woman.
Katz MS; Schapira L; Harisinghani MG; Hughes KS
Nat Clin Pract Oncol; 2005 Apr; 2(4):218-21; quiz 1 p following 222. PubMed ID: 16264937
[TBL] [Abstract][Full Text] [Related]
13. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
[TBL] [Abstract][Full Text] [Related]
14. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
15. Management of advanced breast cancer: a case report.
Gupta AK; Ticku JL
Indian J Med Sci; 1999 Jun; 53(6):267-9. PubMed ID: 10776508
[No Abstract] [Full Text] [Related]
16. A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinoma.
Rashid MU; Shah MA; Azhar R; Syed AA; Amin A; Hamann U
Pathol Res Pract; 2011 Sep; 207(9):583-6. PubMed ID: 21723046
[TBL] [Abstract][Full Text] [Related]
17. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
[No Abstract] [Full Text] [Related]
18. Breast cancer (non-metastatic).
Dixon JM; Rodger A; Stebbing J
Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
[No Abstract] [Full Text] [Related]
19. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
20. TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy.
Henríquez-Hernández LA; Pérez LF; Hernández AG; de León AC; Díaz-Chico B; Rosales AM
Cancer Epidemiol; 2010 Aug; 34(4):490-3. PubMed ID: 20371218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
